This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

GlaxoSmithKline: Upgrades, Downgrades


Barnes & Noble (BKS - Get Report) downgraded at BofA/Merrill to Underperform from Neutral on uncertainty surrounding the company's digital initiatives and a deteriorating balance sheet. Price target reduced to $13 from $15.

Danaher (DHR - Get Report) rated new Buy at Citigroup. $47 price target. Recent acquisitions boost the company's growth profile.

Emerson Electric (EMR - Get Report) rated new Hold at Citigroup. $53 price target. Company appears to have overpaid for a recent acquisition and is at risk if growth in China slows down.

General Electric (GE - Get Report) rated new Buy at Citigroup. $19 price target. Company should be able to rescue its earnings growth.

GlaxoSmithKline (GSK - Get Report) downgraded at Jefferies from Buy to Hold. Risk is increasing that Avandia could be removed from the market.

Honeywell (HON - Get Report) rated new Hold at Citigroup. $45 price target. Company continues to face headwinds in aerospace and commercial construction.

3M (MMM) rated new Hold at Citigroup. Valuation call, based on a $90 price target.

Micron Technology (MU) downgraded at Goldman from Buy to Neutral. $7.85 price target. Tablet demand is weighing heavily on the PC market. Estimates also lowered.

Maxim Integrated (MXIM) downgraded at Goldman from Neutral to Sell. $16 price target. Valuation call. Stock has a 5% dividend yield, but also faces margin compression.

Netlogic Microsystem (NETL) upgraded at UBS from Neutral to Buy. $33.50 price target. Stock has pulled back 25% since earnings, and the company should deliver solid fourth-quarter growth.

Nalco (NLC) rated new Buy at Janney. $30 price target. Company is leveraged to continued growth in the water sector.

Nokia (NOK - Get Report) downgraded at Citigroup from Hold to Sell. $7.93 price target. Company should not trade at a premium to its peers.

NXP Semiconductors (NXPI) initiated at Barclays with an Overweight rating and $18 price target. Above industry sales growth combined with solid margin expansion drives positive view.

NXP Semiconductors (NXPI) initiated at Credit Suisse with an Outperform rating and $16 price target. Key drivers: margin expansion and financial deleveraging.

Reynolds American (RAI) upgraded at BofA/Merrill to Neutral from Underperform on healthy volume trends. Price target jumped to $59 from $52.

Rowan (RDC) upgraded at UBS from Neutral to Buy. $42 price target. High specification jackup dayrates are moving up ahead of expectations.

Tyco (TYC) downgraded at BofA/Merrill to Neutral from Buy, valuation call. No change to $45 price target.
1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
BKS $8.30 3.00%
DHR $84.08 -1.30%
EMR $45.50 -0.59%
GSK $39.17 0.10%
GE $27.58 -2.50%


Chart of I:DJI
DOW 15,781.23 +121.05 0.77%
S&P 500 1,829.08 -22.78 -1.23%
NASDAQ 4,266.8370 -16.7550 -0.39%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs